NPC joins an impressive roster of corporate, strategic and private investors who see the tremendous market potential in NovoBind’s platform to create custom biologicals to reduce the use of antibacterial chemicals, and fight the global war on antimicrobial resistance.
“NovoBind has attracted a strong group of investors that bring a diverse set of expertise and skills to help the company reach its full potential,” says Shelley King, CEO of Natural Products Canada